High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer

High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer

There have been few reports about high total dose hypofractionated proton beam therapy for central lung cancer. The aim of this study was to examine retrospectively the safety and efficacy of high total dose hypofractionated proton beam therapy for central lung cancer.

Bibliographic Details
Main Authors: Ono Takashi, Yabuuchi Tomonori, Nakamura Tatsuya, Kimura Kanako, Azami Yusuke, Hirose Katsumi, Suzuki Motohisa, Wada Hitoshi, Kikuchi Yasuhiro, Nemoto Kenji
Format: Article
Language:English
Published: Sciendo 2017-06-01
Series:Radiology and Oncology
Subjects:
central
lung cancer
hypofractionated
proton beam therapy
Online Access:https://doi.org/10.1515/raon-2017-0023

Internet

https://doi.org/10.1515/raon-2017-0023

Similar Items